SEC FORM 4
$677.40
Evogene Ltd. (EVGN)
Purchase of 1,129 shares at $0.6 per share.
Reporting Person Tarcic Gabi · Officer Title Chief Development Officer · Transaction Code P
Traded Jun 4, 2026 · Disclosed Aug 26, 2026FILED +83 DAYS
Source: SEC Form 4 · 0001178913-26-004259 · filed 2026-08-26 · View filing →